Using propensity score matching, patients with clinical stage I NSCLC who underwent either VATS lobectomy or stereotactic body radiotherapy (SBRT) were compared for long-term outcomes. Among 37 matched pairs, tumor control at 3 years was twice as good for surgery (p=.0038), cancer-specific survival was 15 percentage points better for surgery (p=.055), and overall survival and recurrence-free survival were superior for surgery (p
You are here:
VATS Lobectomy Is Associated With Greater Recurrence-Free Survival Than SBRT for Clinical Stage I Lung Cancer
Submitted by: Mark Ferguson
Source: Journal of Thoracic and Cardiovascular Surgery
Keywords:
Author(s): Lorraine D. Cornwell, Alfredo E. Echeverria, Jason Samuelian, Jessica Mayor, Roberto F. Casal, Faisal G. Bakaeen, Shuab Omer, Ourania Preventza, Weiyuan Mai, George Chen, Katherine H. Simpson, Drew Moghanaki, Angela W. Zhu
1 Comment
I guess SBRT is still a questionable palliation modality for unfit patients with CURABLE bronchial carcinomas……..